
无数据
无数据
无数据
| CAS Number | 1786-81-8 |
| Catalog Number | AG00266D(AGN-PC-0QBEMU) |
| Chemical Name | 2-(Propylamino)-o-propionotoluidide hydrochloride |
| EC Number | 217-244-0 |
| IUPAC Name | N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride |
| InChI | InChI=1S/C13H20N2O.ClH/c1-4-9-14-11(3)13(16)15-12-8-6-5-7-10(12)2;/h5-8,11,14H,4,9H2,1-3H3,(H,15,16);1H |
| InChI Key | BJPJNTKRKALCPP-UHFFFAOYSA-N |
| MDL Number | MFCD00079279 |
| Molecular Formula | C13H21ClN2O |
| Molecular Weight | 256.7716 |
| NSC Number | 758432 |
| SMILES | CCCNC(C(=O)Nc1ccccc1C)C.Cl |
| Synonyms | Citanest,
Citanest Octapressin,
Prilocaine,
Prilocaine Hydrochloride,
Propitocaine,
Xylonest,
Prilocaine hydrochloride,
1786-81-8,
Propitocaine hydrochloride,
Prilocaine HCl,
Xylonest,
Prilocaine chloride,
Citanest hydrochloride,
Citanest plain,
Astra 1512,
N-(2-Methylphenyl)-2-(propylamino)propanamide hydrochloride,
Prilocaine (hydrochloride),
2-(Propylamino)-,
2-(Propylamino)-o-propionotoluidide hydrochloride,
L-67,
EINECS 217-244-0,
MFCD00079279,
MLS000069690,
2-(Propylamino)-N-(o-tolyl)propanamide hydrochloride,
2-(Propylamino)-o-propionotoluidide monohydrochloride,
alpha-Propylamine-2-methyl-propionanilide hydrochloride,
o-Propionotoluidide, 2-(propylamino)-, monohydrochloride,
SMR000058506,
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, monohydrochloride,
DSSTox_CID_11956,
DSSTox_RID_78897,
DSSTox_GSID_31956,
878791-35-6,
Q-201619,
N-(2-methylphenyl)-2-(propylamino)propanamide;hydrochloride,
CHEBI:32053,
SR-01000076094,
L 67,
Propitocaine HCl,
Prilocaine hydrochloride [USAN],
Prilocaine, HCl,
Citanest (TN),
Prestwick_616,
Prilocaine hydrochloride [USAN:USP],
L 67 Hydrochloride,
prilocaine-hydrochloride,
Propitocainehydrochloride,
Opera_ID_480,
AC1L3NJV,
NCGC00016594-01,
CAS-1786-81-8,
MLS002222230,
MLS002548864,
ARONIS24439,
SCHEMBL330180,
SPECTRUM1503270,
2-(Propylamino)-N-(o-tolyl)propionamide Hydrochloride,
Prilocaine hydrochloride (USP),
CHEMBL1200586,
DTXSID2031956,
CTK8G2574,
HY-B0137A,
Propitocaine hydrochloride (JAN),
BBC/603,
EBD2408,
HMS1568H19,
HMS1922O15,
Pharmakon1600-01503270,
Prilocaine HCl (Propitocaine HCl),
ACT04757,
BCP22337,
ZX-AS004804,
Tox21_110513,
Tox21_501005,
BG0296,
CCG-39327,
DT1296,
FC1266,
GP0348,
NSC758432,
AKOS015895106,
Propanamide, N-(2-methylphenyl)-2-(propylamino)-, hydrochloride (1:1),
Tox21_110513_1,
AC-2099,
API0003927,
CS-1930,
KS-5024,
LP01005,
LS-2121,
MCULE-7993425453,
NC00474,
NSC-758432,
NCGC00015860-06,
NCGC00094299-01,
NCGC00094299-02,
NCGC00094299-03,
NCGC00094299-04,
NCGC00094299-05,
NCGC00261690-01,
AN-14287,
BC209185,
CPD000058506,
Prilocaine hydrochloride, >=98% (TLC),
SAM002264640,
SC-22683,
SY066795,
BCP0726000006,
AB0005494,
AB1004860,
AX8040365,
LS-119349,
LS-119350,
LS-119351,
EU-0101005,
FT-0633840,
P2038,
ST24049036,
ST51015112,
MFCD00079279 (97%),
D01243,
EN300-188472,
J10292,
M-1534,
P 9547,
2-(Propylamino)-m-propionotoluidide Hydrochloride,
2-(propylamino)-N-o-tolylpropanamide hydrochloride,
786P818,
A812391,
I06-0422,
SR-01000076094-1,
SR-01000076094-6,
N-(2-methylphenyl)-N2-propylalaninamide hydrochloride,
N-(o-tolyl)-2-(propylamino)propanamide hydrochloride,
N-(2-methylphenyl)-2-(propylamino)propanamide, chloride,
PRILOCAINE HYDROCHLORIDE (PRILOCAINE (721-50-6)),
Prilocaine hydrochloride, meets USP testing specifications,
N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride,
Prilocaine hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Prilocaine for peak identification, European Pharmacopoeia (EP) Reference Standard,
Prilocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard,
2-(Propylamino)-o-propionotoluidide hydrochloride; N-(2-Methylphenyl)-2-(propylamino)-propanamide hydrochloride,
Citanest,
Citanest Forte,
Mixture Name,
UNII-MJW015BAPH,
MJW015BAPH,
C13H21ClN2O,
C13H20N2O.HCl,
C13-H20-N2-O.Cl-H,
CID92163,
ACN-028686,
CS-P-00474,
N-(3-Methylphenyl)-2-(propylamino)propanamide Hydrochloride,
Prilocaine hydrochloride, 99%, a local anesthetic of the amino amide type - 1G 1g,
4H-Pyrano[2,3-b][1,4]benzodioxin-4-one, decahydro-4a,7,9-trihydroxy- 2-methyl-6,8-bis(methylamino)-, (2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-,
|
| Complexity | 218 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 256.134g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 17 |
| Hydrogen Bond Acceptor Count | 2 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 256.774g/mol |
| Monoisotopic Mass | 256.134g/mol |
| Rotatable Bond Count | 5 |
| Topological Polar Surface Area | 41.1A^2 |
| Undefined Atom Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Symbol: | |
| Hazard statements | |
| Precautionary statements | |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

